Quality-of-life in Charcot-Marie-Tooth disease: The patient's perspective

Neuromuscular Disorders

Volumn 24, Issue 11, 2014, Pages 1018-1023

  Johnson, Nicholas E ^a   Heatwole, Chad R ^b   Dilek, Nuran ^b   Sowden, Janet ^b   Kirk, Callyn A ^c   Shereff, Denise ^c   Shy, Michael E ^d   Herrmann, David N ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Charcot Marie Tooth disease; Patient reported outcomes; Peripheral neuropathy; Quality of life

Indexed keywords

ADULT; AGE; ARTICLE; BALANCE IMPAIRMENT; BODY IMAGE; DISEASE CLASSIFICATION; DISEASE DURATION; EMOTION; EMPLOYMENT STATUS; FATIGUE; FEMALE; FOOT DISEASE; GASTROINTESTINAL DISEASE; HEREDITARY MOTOR SENSORY NEUROPATHY; HIP DISEASE; HUMAN; LIMB WEAKNESS; LIMITED MOBILITY; MAJOR CLINICAL STUDY; MALE; PAIN; PREVALENCE; QUALITY OF LIFE; SEX DIFFERENCE; AGED; CHARCOT-MARIE-TOOTH DISEASE; EMPLOYMENT; HEALTH SURVEY; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; CHARCOT-MARIE-TOOTH DISEASE; EMPLOYMENT; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE;

EID: 84922328260     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.06.433     Document Type: Article

References (9)

1. Reilly M.M., Shy M.E. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry 2009, 80:1304-1314.
2. Redmond A.C., Burns J., Ouvier R.A. Factors that influence health-related quality of life in Australian adults with Charcot-Marie Tooth disease. Neuromuscul Disord 2008, 18(8):619-625.
3. Padua L., Shy M.E., Aprile I., et al. Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst 2008, 13(1):64-70.
4. Burns J., Ramchandren S., Ryan M.M., et al. Determinants of reduced health-related quality of life in pediatric inherited neuropathies. Neurology 2010, 75:726-731.
5. Boentert M., Dziewas R., Heidbreder A., et al. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J Neurol 2010, 257:646-652.
6. Johnson N.E., Heatwole C.R., Ferguson M., et al. Patient identification of the symptomatic impact of Charcot Marie Tooth disease type 1A. J Clin Neuromuscul Dis 2013, 15(1):19-23.
7. Bren L. The importance of patient-reported outcomes...it's all about the patients. FDA Consum 2006, 40:26-32.
8. Patrick D.L., Burke L.B., Powers J.H., et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007, 10(Suppl. 2):S125-S137.
9. Heatwole C., Bode R., Johnson N., et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 2012, 79:348-357.